ResMed Goodwill and Intangible Assets 2010-2025 | RMD

ResMed goodwill and intangible assets from 2010 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
  • ResMed goodwill and intangible assets for the quarter ending March 31, 2025 were $3.279B, a 1.74% decline year-over-year.
  • ResMed goodwill and intangible assets for 2024 were $3.328B, a 0.16% increase from 2023.
  • ResMed goodwill and intangible assets for 2023 were $3.323B, a 45.58% increase from 2022.
  • ResMed goodwill and intangible assets for 2022 were $2.282B, a 1.64% decline from 2021.
ResMed Annual Goodwill and Intangible Assets
(Millions of US $)
2024 $3,328
2023 $3,323
2022 $2,282
2021 $2,320
2020 $2,338
2019 $2,378
2018 $1,284
2017 $1,327
2016 $1,359
2015 $311
2014 $335
2013 $324
2012 $311
2011 $283
2010 $230
2009 $248
ResMed Quarterly Goodwill and Intangible Assets
(Millions of US $)
2025-03-31 $3,279
2024-12-31 $3,243
2024-09-30 $3,365
2024-06-30 $3,328
2024-03-31 $3,337
2023-12-31 $3,390
2023-09-30 $3,375
2023-06-30 $3,323
2023-03-31 $3,353
2022-12-31 $3,354
2022-09-30 $2,277
2022-06-30 $2,282
2022-03-31 $2,302
2021-12-31 $2,323
2021-09-30 $2,297
2021-06-30 $2,320
2021-03-31 $2,336
2020-12-31 $2,323
2020-09-30 $2,333
2020-06-30 $2,338
2020-03-31 $2,349
2019-12-31 $2,352
2019-09-30 $2,353
2019-06-30 $2,378
2019-03-31 $2,456
2018-12-31 $2,244
2018-09-30 $1,434
2018-06-30 $1,284
2018-03-31 $1,309
2017-12-31 $1,315
2017-09-30 $1,323
2017-06-30 $1,327
2017-03-31 $1,317
2016-12-31 $1,322
2016-09-30 $1,352
2016-06-30 $1,359
2016-03-31 $573
2015-12-31 $466
2015-09-30 $305
2015-06-30 $311
2015-03-31 $302
2014-12-31 $321
2014-09-30 $324
2014-06-30 $335
2014-03-31 $337
2013-12-31 $337
2013-09-30 $332
2013-06-30 $324
2013-03-31 $328
2012-12-31 $338
2012-09-30 $333
2012-06-30 $311
2012-03-31 $327
2011-12-31 $323
2011-09-30 $332
2011-06-30 $283
2011-03-31 $280
2010-12-31 $270
2010-09-30 $272
2010-06-30 $230
2010-03-31 $251
2009-12-31 $265
2009-09-30 $257
2009-06-30 $248
2009-03-31 $236
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $37.302B $4.685B
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.693B 27.62
Boston Scientific (BSX) United States $152.679B 38.22
Stryker (SYK) United States $148.653B 31.08
EssilorLuxottica (ESLOY) France $131.422B 0.00
Medtronic (MDT) Ireland $115.326B 16.35
Lonza Group Ag (LZAGY) Switzerland $49.666B 0.00
Haleon (HLN) United Kingdom $44.744B 25.54
Agilent Technologies (A) United States $35.020B 22.83
GE HealthCare Technologies (GEHC) United States $34.401B 16.33
Terumo (TRUMY) Japan $24.607B 31.96
Koninklijke Philips (PHG) Netherlands $23.139B 16.24
Insulet (PODD) United States $20.361B 79.92
Zimmer Biomet Holdings (ZBH) United States $18.556B 11.92
Baxter (BAX) United States $14.728B 11.00
Smith & Nephew SNATS (SNN) United Kingdom $13.262B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.993B 24.33
Lantheus Holdings (LNTH) United States $5.626B 14.19
Perrigo (PRGO) Ireland $3.785B 9.59
Prestige Consumer Healthcare (PBH) United States $3.780B 16.89
Haemonetics (HAE) United States $3.628B 16.52
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.424B 28.45
ICU Medical (ICUI) United States $3.253B 23.99
QuidelOrtho (QDEL) United States $2.052B 14.11
LeMaitre Vascular (LMAT) United States $1.891B 42.26
AtriCure (ATRC) United States $1.521B 0.00
Acuren (TIC) United States $1.395B 0.00
Green Thumb Industries (GTBIF) United States $1.389B 31.24
Phibro Animal Health (PAHC) United States $1.248B 15.96
AdaptHealth (AHCO) United States $1.244B 12.63
Neogen (NEOG) United States $1.170B 14.97
BioLife Solutions (BLFS) United States $1.050B 0.00
InMode (INMD) Israel $0.930B 9.37
Curaleaf Holdings (CURLF) Canada $0.771B 0.00
Kestra Medical Technologies (KMTS) United States $0.766B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.695B 0.00
Owens & Minor (OMI) United States $0.627B 5.21
Evolus (EOLS) United States $0.611B 0.00
Tilray Brands (TLRY) Canada $0.584B 0.00
CeriBell (CBLL) United States $0.583B 0.00
Valneva SE (VALN) France $0.517B 0.00
Surmodics (SRDX) United States $0.441B 0.00
SNDL (SNDL) Canada $0.365B 0.00
Capricor Therapeutics (CAPR) United States $0.349B 0.00
VAREX IMAGING (VREX) United States $0.337B 12.38
Cresco Labs (CRLBF) United States $0.323B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Sanuwave Health (SNWV) United States $0.298B 0.00
Quanterix (QTRX) United States $0.294B 0.00
Cerus (CERS) United States $0.277B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.47
Sanara MedTech (SMTI) United States $0.258B 0.00
Aurora Cannabis (ACB) Canada $0.252B 74.83
ZimVie (ZIMV) United States $0.251B 11.39
Verano Holdings (VRNOF) United States $0.235B 0.00
Brainsway (BWAY) Israel $0.233B 61.55
OraSure Technologies (OSUR) United States $0.232B 0.00
Biote (BTMD) United States $0.223B 6.28
Omeros (OMER) United States $0.214B 0.00
Canopy Growth (CGC) Canada $0.208B 0.00
Organigram Global (OGI) Canada $0.194B 0.00
High Tide (HITI) Canada $0.191B 0.00
TriSalus Life Sciences (TLSI) United States $0.185B 0.00
Utah Medical Products (UTMD) United States $0.183B 14.93
Vireo Growth (VREOF) United States $0.163B 0.00
Exagen (XGN) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.122B 0.00
TerrAscend (TSNDF) Canada $0.117B 0.00
MacroGenics (MGNX) United States $0.102B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.098B 12.68
Jushi Holdings (JUSHF) United States $0.090B 0.00
Veru (VERU) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.081B 0.00
Apyx Medical (APYX) United States $0.079B 0.00
Agape ATP (ATPC) $0.074B 0.00
InterCure (INCR) Israel $0.071B 0.00
Zynex (ZYXI) United States $0.068B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Rockwell Medical (RMTI) United States $0.039B 0.00
Modular Medical (MODD) United States $0.039B 0.00
Nephros (NEPH) United States $0.038B 51.43
United-Guardian (UG) United States $0.037B 12.89
Safety Shot (SHOT) United States $0.034B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00